Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study

Grey matter atrophy has been shown in primary progressive multiple sclerosis (PPMS), but its association with physical incapacity is unclear. We submitted 19 patients with PPMS to a neurological evaluation and brain magnetic resonance imaging (MRI) with volumetric analysis using FreeSurfer. We found no relation between the Expanded Disability Status Scale or disease duration and the grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes, but not with total white matter volume. We concluded that physical disability in PPMS is not directly related to brain atrophy and that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration. Long abstract Introduction: Primary progressive multiple sclerosis (PPMS) is characterized by chronic progression since onset, with predominant involvement of the spinal cord and prominent neurodegeneration. Grey matter atrophy has been shown in patients with PPMS, but its association with clinical incapacity is uncertain. We investigated the relationship between regional brain atrophy and physical disability in patients with PPMS. Methods Patients with an established diagnosis of PPMS underwent a neurological evaluation followed by brain MRI at 1.5 T. Volumetric analysis was performed with FreeSurfer software, and evaluated the neocortex, total white matter, total subcortical grey matter, putamen, caudate, globus pallidus, thalamus, hippocampus, brainstem, corpus callosum and pre-central gyrus volumes. Clinical data obtained included physical disability as measured by the Expanded Disability Status Scale (EDSS). Results Nineteen patients were included, 14 female (73.7%), mean age of 55.7 (SD 7.6) and mean disease duration of 13.0 years (SD 8.8). Median EDSS score was 6.0 (3.5–8.0). The average T1 lesion load (4.9 cm3, SD 3.4) and T2 load (10.5 cm3, SD 9.9) did not relate to disease duration. There was no significant correlation between EDSS score or disease duration and the cortical grey matter, deep grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes (p < 0.05), but not with total white matter volume. Conclusions Physical disability in PPMS is not directly related to brain volume loss. Grey matter atrophy correlates with lesion load in patients with PPMS, indicating that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration.

[1]  Peter A. Calabresi,et al.  Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis , 2012, PloS one.

[2]  F. Barkhof,et al.  Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  Massimo Filippi,et al.  Magnetic resonance techniques in multiple sclerosis: the present and the future. , 2011, Archives of neurology.

[4]  Peter K. Stys,et al.  Will the real multiple sclerosis please stand up? , 2012, Nature Reviews Neuroscience.

[5]  M. Filippi,et al.  The role of magnetic resonance imaging in the study of multiple sclerosis: diagnosis, prognosis and understanding disease pathophysiology. , 2011, Acta neurologica Belgica.

[6]  Christine C. Boucard,et al.  White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI , 2013, Multiple sclerosis.

[7]  L D Blumhardt,et al.  Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. , 1999, Brain : a journal of neurology.

[8]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[9]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[10]  Alan J. Thompson,et al.  Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis , 2004, NeuroImage.

[11]  AJ Thompson,et al.  A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis , 2011, Multiple sclerosis.

[12]  Mara Cercignani,et al.  Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM , 2009, Human brain mapping.

[13]  I. Pirko,et al.  Neuroimaging of demyelination and remyelination models. , 2008, Current topics in microbiology and immunology.

[14]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[15]  David H. Miller,et al.  Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial , 2010, The Lancet Neurology.

[16]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[17]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[18]  Chunshui Yu,et al.  Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study. , 2012, European journal of radiology.

[19]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[20]  A. Thompson,et al.  Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  Gerard R. Ridgway,et al.  Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis , 2014, NeuroImage.

[22]  O. Ciccarelli,et al.  Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis , 2011, Multiple sclerosis.

[23]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[24]  J. Raduà,et al.  Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability , 2013, Neuroscience & Biobehavioral Reviews.

[25]  Massimo Filippi,et al.  A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes , 2008, NeuroImage.

[26]  Frederik Barkhof Making better use of our brain MRI research data , 2012, European Radiology.

[27]  David J. Miller,et al.  Multiple sclerosis: new insights and therapeutic progress , 2007, The Lancet Neurology.

[28]  A. Giorgio,et al.  Cognition in multiple sclerosis: relevance of lesions, brain atrophy and proton MR spectroscopy , 2010, Neurological Sciences.

[29]  J K Udupa,et al.  Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.

[30]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Ludwig Kappos,et al.  Longitudinal gray matter changes in multiple sclerosis—Differential scanner and overall disease‐related effects , 2012, Human brain mapping.

[32]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[33]  M. Filippi,et al.  Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype , 2011, Human brain mapping.

[34]  D. Chard,et al.  Advances in Imaging to Support the Development of Novel Therapies for Multiple Sclerosis , 2012, Clinical pharmacology and therapeutics.

[35]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[36]  G. Siracusa,et al.  Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis , 2008, Neurology.

[37]  Rohit Bakshi,et al.  Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study , 2003, Neuroreport.

[38]  Jayaram K. Udupa,et al.  Comparison of T 2 Lesion Volume and Magnetization Transfer Ratio Histogram Analysis and of Atrophy and Measures of Lesion Burden in Patients with Multiple Sclerosis , 1998 .

[39]  A. J. Thompson,et al.  Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability , 2007, NeuroImage.

[40]  Marco Battaglini,et al.  Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis , 2009, Journal of the Neurological Sciences.